Welcome to our dedicated page for Honeywell Intl SEC filings (Ticker: HON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Honeywell International Inc. spans cockpit avionics to smart-building thermostats, so its SEC disclosures cover everything from jet-engine aftermarket margins to carbon-capture licensing fees. That breadth fuels questions like “where can I read Honeywell insider trading Form 4 transactions?� or “how do I decode Honeywell’s quarterly earnings report 10-Q filing?�
StockTitan’s AI unpacks each document instantly. Want the Honeywell annual report 10-K simplified? We translate segment sales, pension liabilities, and Honeywell Forge software growth into plain language. Tracking an 8-K material event? AG˹ٷ-time alerts explain the implications. When executives post Honeywell Form 4 insider transactions real-time, our summaries show whether they’re exercising options or buying on the open market—no EDGAR tables required.
Every filing type is here and searchable: 10-Q earnings updates with margin walk-throughs, proxy statement executive compensation tables, S-3 shelf registrations, and more. Updates appear the moment Honeywell files, and AI-powered highlights guide you to cash-flow drivers, aerospace backlog changes, and environmental commitments.
- Monitor Honeywell executive stock transactions Form 4 before material announcements
- Compare aerospace versus building-tech growth across quarters
- Understand Honeywell SEC filings explained simply—no accounting degree required
Whether you need Honeywell earnings report filing analysis for a model or Honeywell 8-K material events explained ahead of a trade, StockTitan turns regulatory paperwork into actionable clarity.
Honeywell International (HON) Form 144 filing discloses a planned sale of 3,448 common shares through Morgan Stanley Smith Barney on or about 01 Aug 2025. Based on the filer’s reference price, the transaction is valued at $752,026. The shares originate from recent restricted-stock vesting and option exercises under Honeywell’s equity-compensation plans. With 634.9 million shares outstanding, the proposed sale equals roughly 0.0005 % of total shares.
No sales have been reported in the past three months, and the signer certifies possession of no undisclosed adverse information, as required by Rule 144. Because Form 144 only signals intent, the sale may or may not be executed. Given the modest size relative to Honeywell’s float and average trading volumes, the filing appears to be routine insider activity with limited market impact.
Universal Insurance Holdings, Inc. (UVE) filed a Form 4 for director Marlene Gordon covering a single transaction on 28 Jul 2025.
- Security granted: 2,824 restricted common shares at $0 cost.
- Post-grant ownership: 25,061 UVE shares held directly.
- Vesting schedule: the restricted shares fully vest on 28 Jul 2026.
No derivative securities were involved, and the filing reports only one insider. Because the shares were awarded rather than purchased on the open market, the transaction mainly reflects compensation rather than incremental insider buying pressure. The size of the award is modest relative to UVE’s public float, but it modestly increases insider ownership and may modestly align the director’s incentives with shareholders.
Honeywell (HON) has signed an agreement to terminate its 2018 Indemnification and Reimbursement Agreement with Resideo. In exchange for cancelling all future variable payments (capped at $140 M per year through 2043), Resideo Intermediate Holding (RIH) will make a one-time cash payment of $1.59 B to Honeywell at closing, expected no later than 29 Aug 2025 (extension to 30 Oct 2025 at Honeywell’s option). A scheduled $35 M quarterly payment was already received on 29 Jul 2025.
From signing to closing, scheduled indemnity payments are suspended and, if closing occurs, permanently forgiven. If the deal fails to close and Honeywell terminates after 29 Aug 2025 (or Resideo after 30 Oct 2025), Resideo must pay a $100 M liquidated-damage fee and the original indemnity agreement remains in force with accrued interest (5% p.a.). Resideo and RIH represent that committed financing, plus cash on hand, will cover the payment; their obligations are not conditioned on funding.
Separately, Honeywell’s Board amended and restated the company By-laws on 25 Jul 2025, adding Article V, Section 17 to designate a Senior Management Official for U.S. National Industrial Security Program compliance.
Honeywell International (HON) President & CEO, BA division, Billal Hammoud reported insider activity for 28 Jul 2025.
- M code: 627 common shares were acquired through the conversion of vested restricted stock units (1-for-1).
- F code: 247 shares were concurrently sold at $226.24 to cover tax-withholding obligations.
The net effect is an increase of +380 shares. Hammoud now holds 4,198 shares directly and 303.1826 shares indirectly in the company 401(k) plan. The filing also notes 607 unvested RSUs scheduled to vest on 28 Jul 2026.
Because the transactions stem from routine equity-compensation vesting, involve fewer than 0.0001 % of Honeywell’s ~670 million diluted shares, and were not open-market buys/sells, the disclosure is unlikely to move the stock.
On 07/25/2025 Honeywell International (HON) insider James E. Currier, President & CEO of Aero Technologies, reported routine equity settlement activity. He converted 662 restricted stock units (RSUs) into common stock under the 2016 Stock Incentive Plan (transaction code “M�). Concurrently, 267 shares were withheld for taxes (code “F�), leaving a net addition of 395 shares to his direct ownership. Post-transaction, Currier directly owns 2,936 HON shares and indirectly holds 710.0551 shares in the company 401(k) plan.
The RSUs, which vest one-for-one into common stock and include 75 units from dividend reinvestment, fully vested on the transaction date, and no derivative positions remain. Because the share count is immaterial compared with Honeywell’s ~670 million shares outstanding, the filing does not signal a directional change in insider sentiment and is unlikely to influence valuation.
Honeywell International (HON) Form 4: President & CEO, ESS, Kenneth J. West reported routine equity transactions dated 25 Jul 2025.
- 552 common shares acquired through the exercise/settlement of Restricted Stock Units (transaction code M). RSUs convert 1-for-1 into common stock.
- 258 shares automatically sold at $224.45 (code F) to cover tax-withholding obligations tied to the vesting event.
- Post-transaction ownership: 2,114 shares held directly and 606.6096 shares held indirectly in the 401(k) plan. All derivative RSUs reported in this filing are now fully settled; zero remain outstanding.
These transactions appear non-open-market and compensation-related, with no indication of discretionary buying or selling. The scale (≈US$124k acquired, ≈US$58k withheld) is immaterial relative to Honeywell’s market capitalization and is unlikely to influence shareholder valuation.
Item 3.02: On 23 Jul 2025 Regency Centers, L.P., the operating partnership of Regency Centers Corp. (REG), issued 2,773,083 limited common partnership units at $72.00 each, raising roughly $200 million under the Section 4(a)(2) private-placement exemption. Proceeds are being used to help fund the acquisition of five grocery-anchored shopping centers in Orange County, CA.
The units carry an initial lock-up period and may thereafter be exchanged, at holder option and the Company’s discretion, for cash or one share of REG common stock, introducing potential dilution. No other securities were registered.
Item 7.01: A press release dated 24 Jul 2025 (Ex. 99.1) confirms the transaction’s closing; the release is furnished, not filed. No financial statements accompanied this Form 8-K.
On 24 Jul 2025, KB Financial Group (KB) filed a Form 6-K disclosing board approval of a �660 bn treasury‐share buyback via a trust agreement with Hana Securities. The programme runs from 24 Jul 2025 to 9 Jan 2026 and is calculated to acquire up to 5,724,197 common shares at the prior-day closing price of �115,300. KB already holds 17.31 m treasury shares (4.54% of outstanding).
Key terms
- Purpose: enhance shareholder return and corporate value; shares are slated for cancellation within one year after the trust ends.
- Total contract amount represents c.66% of the �999.2 bn headroom allowed under Korean Commercial Code after dividends and prior repurchases.
- Funding source: profits available for dividends—no new debt announced.
- Counterparty: Hana Securities Co., Ltd.
The action signals management confidence in capital strength and should be EPS-accretive if executed as planned. No earnings or guidance updates were provided.